What's in Alder Biopharmaceuticals, Inc.'s pipeline?

Alder Biopharmaceuticals, Inc. has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Alder Biopharmaceuticals, Inc.'s portfolio?

Top competitors by shared drug class: Amgen, Beth Israel Deaconess Medical Center, Hospital Clínico Universitario de Valladolid.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/alder-biopharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Alder Biopharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Alder Biopharmaceuticals, Inc. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
ALD403 (Eptinezumab)	ALD403 (Eptinezumab)	phase 3	CGRP monoclonal antibody	CGRP (Calcitonin Gene-Related Peptide)	Neurology
ALD403	ALD403	phase 3	CGRP monoclonal antibody	CGRP (Calcitonin Gene-Related Peptide)	Neurology

Therapeutic area mix

Neurology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Amgen · 1 shared drug class
Beth Israel Deaconess Medical Center · 1 shared drug class
Hospital Clínico Universitario de Valladolid · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Alder Biopharmaceuticals, Inc.:

Cite this brief

Drug Landscape (2026). Alder Biopharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/alder-biopharmaceuticals-inc. Accessed 2026-05-17.